Investment
Editor's Notes: * Pfizer has been a popular "fallen angel" name (8x LTM / FWD P/E and 7% dividend yield), with Michael Burry's bullish call option disclosure in Nov putting it on many people's watchlist. * The heart of the issue is the transition
Investment
Editor's Notes: * Oracle feels like one of the clearest examples of how the AI trade is evolving from a margin story into a balance-sheet story. On the surface, the growth narrative is undeniable: OCI is scaling rapidly, RPO has exploded on the back of the OpenAI deal, and
Investment
Editor's Notes: * This is the stock that 10x over 5 years. Key supplier to TSMC (going where it goes - Arizona plant, Taiwan, etc.) * Stock got further attention earlier today (see our daily brief earlier). * Valuation fair (not cheap) given high-single-digit annual growth at the company level and
Investment
Editor's Notes: * Generated the following recent development review on Luckin, given recent news (potential bid for Blue Bottle), and stock price jump yesterday (~10%), see earlier digest. * I love Luckin for 3 reasons: (1) low cost advantage at scale, which is a sustainable moat against others, (2) aggressive
Investment
Editor's Notes: * Everything related to electricity is hot (e.g. GEV doubled this year)... so we surveyed the upstream electrical equipment sector a few days ago. Then we found everything is expensive, except Nidec. * Nidec's 12x P/E is super cheap relative to its positioning -
Investment
GE Vernova Inc. (GEV) is undergoing a significant transformation, driven by surging AI-related power demand. The company is strategically repositioning, exiting offshore wind to focus on profitable onshore operations and advancing Small Modular Reactors (SMRs). Strong financial projections and substantial order growth, particularly in gas power and electrification, underscore a
Investment
Below we synthesized recent news concerning Campbells Company (CPB) to provide a comprehensive overview of its operational, financial, and strategic developments. The period under review (September-December 2025) highlights significant challenges, strategic shifts, management changes, and a notable PR crisis, alongside routine financial announcements and market assessments. Chronological Narrative of Key
Investment
Hormel Foods Corporation (HRL), a prominent player in the Food Production sector, has experienced a dynamic period marked by strategic portfolio adjustments, significant operational challenges, and a mixed but ultimately positive financial outlook. The company is actively reshaping its business to navigate persistent inflationary pressures and evolving consumer demands. Executive